| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Klunk Donald J | Chief Accounting Officer | C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK | /s/ Thomas D. Scholtes, as Attorney-in-fact for Donald J. Klunk | 04 Sep 2025 | 0001986716 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | G | Common Shares | Tax liability | $66,559 | -1,468 | -13% | $45.34 | 10,135 | 02 Sep 2025 | Direct | F1, F2 |
| transaction | G | Common Shares | Sale | $120,655 | -2,695 | -27% | $44.77 | 7,440 | 03 Sep 2025 | Direct |
| Id | Content |
|---|---|
| F1 | Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3. |
| F2 | Includes 252 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 673 shares under the ESPP. |